媒体中心

6月21日，知名财经商业媒体福布斯发布2021年“中国科技女性榜”，Cytiva大中华区总经理俞丽华女士成功入选，实力诠释科技女性在生物医药行业绽放的“她力量”。

2021年6月2日，Cytiva宣布已经完成对德国科学软件制造商GoSilico的收购，以期进一步巩固公司在生物制药工艺领域的优势，成就客户、造福患者。

Cytiva 制定的可持续发展规划旨在对人类和全球产生积极影响，从而增强经营弹性，适应环境变化。

Cytiva customers will have access to an artificial intelligence platform for optimizing cell culture formulations and to a cell media configurator that enables customization of cell culture media.

Taiyo Pharma Tech’s new production line will make a new type of therapy through Cytiva’s FlexFactory platform. Taiyo Pharma Tech has the honor of being the 100th Cytiva FlexFactory.

AdBIOPRO is conducting research at Sweden’s Testa Center in Uppsala that could lead to new, more efficient ways to produce biological drugs. Since eight of the top ten best-selling approved drugs globally are biologicals, creating more efficiencies in the manufacture of these medicines would have huge potential for the industry, and for patients.